aHUS Observational Long Term Follow-Up
aHUS Observational Long Term Follow-Up
There is growing but limited information on the long term clinical status of aHUS patients
 who have previously received or are continuing to receive treatment with eculizumab. This
 study is designed to collect clinical data that will provide insight into the long-term
 outcomes of patients with aHUS.
Inclusion Criteria:

 -  aHUS patients who participated in any one of the aHUS-eculizumab clinical studies.

 -  aHUS patients or legal representative who are able and willing to given written
 informed consent for their study information to be collected and retained in a
 database.

 Exclusion Criteria:

 -  Not applicable.